Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Nearly forty years after Hiroshima, the United States is to conclude an agreement on nuclear cooperation with China, which has a similar deal with Japan. But the safeguards are not good enough.
Only a decade after the technique for producing monoclonal antibodies sprung serendipitously from an academic line of research, biotechnology companies are thriving on their manufacture.
Present policies on the commissioning of fundamental research seem likely to inhibit major innovation in the long term. An alternative approach may avoid this pitfall.
This month's batch of new products includes a left-handed glove box, stereo magnifying spectacles, Teflon tubing the diameter of human hair and a new version of Triton X-100 detergent.
